The US-Israel HealthTech Hub Program
A Comprehensive Program for HealthTech Startups
Entering the US Market
About the Program
The US-Israel HealthTech Hub program offers
selected Israeli startup companies a comprehensive
US market entry workshop, followed by an extensive
alumni membership.
The one-stop-shop program provides regulatory,
reimbursement and clinical consultations, access to
funding, strategic partners, marketing, and business
opportunities, together with a designated US
office space.
Program Partners
The US-Israel HealthTech Hub Program is
congressionally funded through the US Department
of Health and Human Services (HHS) and
spearheaded by the Advanced Regenerative
Manufacturing Institute (ARMI www.armiusa.org)
in collaboration with
Mass General Brigham health network
(MGB www.massgeneralbrigham.org),
AmCham Israel (www.amcham.co.il),
and other US and Israeli partners.
Application Process
Application is open to Israeli HealthTech startups in
the fields of:
Digital Health, BioConvergence / Bio-Manufacturing,
Medical devices, Pharmaceuticals and Biotech.
Suitable companies will be considered for the
program by an Industry Advisory Board based on
several criteria including level of innovation, market
readiness, company management team and other.
For information and application please contact:
hubs@amcham.co.il
Where and When?
The one-week workshop runs at the New-England
HealthTech Hub located at ARMI's HQ in Manchester,
New Hampshire and at MGB's HQ in Boston, MA.
Two weeks prior to departure, participating
companies will attend a preparatory seminar in Israel,
to provide them detailed workshop information and
enable Hub partners prepare with specific subject
matter experts.
Program planned dates: November 2023, January*,
March, May, July*, September 2024 (*TBF)
• Regulatory: FDA and other US regulatory requirements consultations
• Reimbursement: consultations with US reimbursement experts
• Clinical Studies: access to clinical trial planning resources and potential partnering with top tier medical centers
• Business Development: expertise on market entry and product strategies
• Networking Opportunities: network with top-tier US and Israeli hospitals, US industry leaders, regulators, investors,
and other stakeholders
• Access to data bases: optional for use in clinical trials
• Alumni membership: office space, follow-up support for US market entry
Disclaimer: the information provided here does not guarantee acceptance of any company to the US-Israel HealthTech Hub Program. Program dates may change.
Cohort 1 (July 2023)
Cohort 2 (August 2023)
